¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"linear scleroderma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® scleroderma ÇÑ±Û °øÇÇÁõ
¼³¸í   
  ¸¸¼ºÀûÀ¸·Î °è¼Ó ÁøÇàµÇ¾î ÇǺΰ¡ µÎ²¨¿ö Áö°í µüµüÇØÁö´Â º´À¸·Î, ¼Ò¾Æ¿Í ¾î¸¥¿¡°Ô¼­ ¸ðµÎ ¹ß»ýÇÒ ¼ö ÀÖ°í, Æ¯Â¡ÀûÀ¸·Î ¸ñ°ú µîÀÇ À­ºÎºÐ¿¡¼­ ½ÃÀ۵ǾƷ¡Âʰú ¾ÕÂÊÀ¸·Î ÆÛÁö´Â º´ÀÌ´Ù. À̰ÍÀº ÀÏÁ¾ÀÇ ÀÚ°¡¸é¿ªÁúȯ(ÀÚ½ÅÀÇ ¼¼Æ÷¸¦ À̹°Áú·Î ÀÎÁöÇÏ¿© ¸é¿ª¹ÝÀÀÀ» ÀÏÀ¸Å°´Â Áúȯ)À¸·Î »ý°¢µÇ¸ç, ÇǺοܿ¡ ¶ÇÇÑ ³»ºÎ±â°ü(¿¹¸¦ µé¾î ÄáÆÏ, ÇãÆÄ, ½Äµµ µî)¿¡µµ ¿ª½Ã °°Àº ¹ÝÀÀÀÌ ÀϾ´Ù. Ä¡·á´Â Æ¯ÀÌÇÑ °ÍÀº ¾ø°í, ¸é¿ª¾ïÁ¦Á¦ÀÇ Ä¡·á¿Í ¹°¸®Ä¡·á µîÀ» ÅëÇÑ °í½ÄÀûÄ¡·á¿¡ ±×Ä£´Ù.
¿µ¹® linear accelerator ÇÑ±Û ¼±»ó°¡¼Ó±â
¼³¸í   
  Ä¡·á¹æ»ç¼±°ú¿¡¼­ ÀÌ¿ëÇϴ ±â°è·Î¼­ ÀüÀÚ¸¦ »ý¼ºÇØ ³½´Ù. ÀüÀڴ ´Ü¼øÈ÷ X-¼±°ú´Â ´Ù¸¥ °ÍÀ¸·Î ÀüÀÚ°¡ ±Ý¼Ó¿¡ ºÎµúÇô ³ª¿À´Â °ÍÀÌ X-¼±ÀÌ´Ù. ÀüÀڴ Áø´Ü¸ñÀûº¸´Ù´Â Ä¡·á¸ñÀûÀ¸·Î ÁַΠÇǺÎÀÇ ¾Ç¼ºÁ¾¾ç(¾Ï)¿¡ »ç¿ëµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • linear scleroderma
    ¼±ÇǺΰæÈ­Áõ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • circumscribed scleroderma
    ±¹ÇÑÇǺΰæÈ­Áõ, ±¹¼ÒÇǺΰæÈ­Áõ
  • diffuse scleroderma
    ±¤¹üÀ§ÇǺΰæÈ­Áõ
  • guttate scleroderma
    ¹æ¿ïÇǺΰæÈ­Áõ
  • localized scleroderma
    ±¹ÇÑÇǺΰæÈ­(Áõ)
  • scleroderma
    ÇǺΰæÈ­Áõ, ÇǺα»À½Áõ
  • scleroderma acrosclerosis
    ¸»´ÜÇǺΰæÈ­Áõ
  • scleroderma diabeticorum
    ´ç´¢ÇǺΰæÈ­Áõ
  • scleroderma en bande
    ¶ì¸ð¾çÇǺΰæÈ­Áõ
  • systemic scleroderma
    Àü½ÅÇǺΰæÈ­Áõ
  • general linear model
    ÀϹݼ±Çü¸ðµ¨
  • linear
    ÁÙ(¸ð¾ç)-, ¼±Çü-, ¼±»ó-
  • linear acceleration
    ¼±Çü°¡¼Óµµ
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • linear attenuation coefficient
    ¼±Çü°¨¼è°è¼ö
  • linear correlation
    ¼±Çü»ó°ü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • scleroderma
    ÇǺΰæÈ­Áõ, ÇǺα»À½Áõ
  • linear acceleration
    ¼±Çü°¡¼Ó
  • linear fracture
    ¼±°ñÀý
  • linear regression
    ¼±Çüȸ±Í
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • linear scleroderma
    ¼±»óÇǺΰæÈ­Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • circumscribed scleroderma
    (¢¡localized scleroderma) ±¹ÇÑÇǺΰæÈ­Áõ
  • diffuse scleroderma
    ±¤¹üÀ§ÇǺΰæÈ­Áõ
  • guttate scleroderma
    ¹æ¿ïÇǺΰæÈ­Áõ
  • localized scleroderma
    ±¹ÇÑÇǺΰæÈ­Áõ
  • scleroderma
    ÇǺΰæÈ­Áõ, ÇǺα»À½Áõ
  • scleroderma acrosclerosis
    ¸»´ÜÇǺΰæÈ­Áõ
  • scleroderma diabeticorum
    ´ç´¢º´ÇǺΰæÈ­Áõ
  • scleroderma en bande
    ¶ì¸ð¾çÇǺΰæÈ­Áõ
  • systemic scleroderma
    Àü½ÅÇǺΰæÈ­Áõ
  • linear acceleration
    ¼±Çü°¡¼Ó
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • linear phased array
    ÁÙÀ§»óÂ÷¹è¿­
  • linear sequenced array
    ÁÙ¸ð¾ç¼ø¼­¹è¿­, ¼±Çü¼øÂ÷¹è¿­
  • linear switched array
    ÁÙ±³´ë½Ä¹è¿­
  • linear correlation
    ¼±»ó»ó°ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • guttate scleroderma
    ¹°¹æ¿ï °æÇÇÁõ
  • Linear acceleration
    ¼±»ó°¡¼Ó(àÊ߾ʥáÜ)
  • arrays, linear sequenced
    ¼±Çü ¼øÂ÷ ¹è¿­ (àÊû¡ â÷ó­ ÛÉæê)
  • high linear energy transfer radiation
    °í¼±Çü¿¡³ÊÁöÀüÀ̹æ»ç¼±
  • phased linear array type
    À§»óÂ÷ ¼±Çü ¹è¿­½Ä
  • phased linear array type
    À§»óÂ÷ ¹è¿­½Ä ¼±Çü (êÈßÓó¬ ÛÕÖªãÒ àÊû¡) Æ®·£½ºµà¼­
  • radiation,linear energy transfer (let)
    ¼±»ó¿¡³ÊÁöÀüȯ(àÊß¾¡­ï®üµ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • linear scleroderma
    ¼±»ó °æÇÇÁõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • circumscribed scleroderma
    ±¹ÇѼº) °æÇÇÁõ
  • diffuse scleroderma
    ±¤¹üÀ§ ÇǺΠ°æÈ­Áõ
  • familial scleroderma
    °¡Á·¼º ÇǺΠ°æÈ­Áõ
  • guttate scleroderma
    ¹°¹æ¿ï °æÇÇÁõ
  • localized scleroderma
    ±¹ÇѼº°æÇÇÁõ
  • scleroderma
    ÇǺΰæÈ­Áõ
  • scleroderma
    ÇǺΰæÈ­Áõ,°æÇÇÁõ(Ìãù«ñø)
  • scleroderma
    ÇǺΰæÈ­Áõ(ù«Ý±Ìãûùñø), °æÇÇÁõ(Ìãù«ñø)
  • scleroderma acrosclerosis
    ¸»´Ü°æÇÇ(Áõ)
  • scleroderma diabeticorum
    ´ç´¢º´ °æÇÇ(Áõ)
  • scleroderma en bande
    ¶ì¸ð¾ç °æÇÇ(Áõ)
  • systemic scleroderma
    Àü½Å¼º °æÇÇÁõ(¡­Ìã ù«ñø)
  • systemic sclerosis [=scleroderma]
    Àü½Å¼º°æÈ­Áõ[= °æÇÇÁõ]
  • arrays, linear sequenced
    ¼±Çü ¼øÂ÷ ¹è¿­ (àÊû¡ â÷ó­ ÛÉæê)
  • bullous dermatosis,linear iga
    ¼±»ó IgA (àÊß¾¡­)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • linear absorption coefficient
    ¼±Èí¼ö°è¼ö(àÊýåâ¥Ìõâ¦)
  • linear accelerator
    ¼±Çü°¡¼Ó±â(àÊû¡Ê¥áÜѦ)
  • linear chain
    ¼±Çü(àÊû¡)»ç½½
  • linear correlation
    ¼±Çü »ó°ü(àÊû¡ßÓμ)
  • linear density gradient
    ¼± ¹Ðµµ(à»ÚËÓø)±â¿ï±â
  • linear dichroism
    ¼±Çü ÀÌ»ö¼º(àÊû¡ì£ßäàõ)
  • linear electric field effect
    ¼±Çü Àü±âÀåÈ¿°ú(àÊû¡ï³Ñ¨íÞüùÍý)
  • linear energy transfer
    ¼±Çü(àÊû¡) ¿¡³ÊÁöÀüÀÌ(ï®ì¹)
  • linear growth
    ¼±Çü¼ºÀå(àÊû¡à÷íþ)
  • linear inhibition
    ¼±ÇüÀúÇØ(àÊû¡îÁúª)
  • linear metabolic pathway
    ¼±Çü ´ë»ç°æ·Î(àÊû¡ÓÛÞóÌèÖØ)
  • linear polymer
    ¼±ÇüÁßÇÕü(àÊû¡ñìùêô÷)
  • linear polyphosphate
    ¼±ÇüÁßÀλê(àÊû¡ñììÝß«)
  • linear regression
    ¼±Çüȸ±Í(àÊû¡üÞÏý)
  • linear transformation
    ¼±ÇüÀüȯ(àÊû¡ï®üµ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • scleroderma
    ÇǺΰæÈ­Áõ, °æÇÇÁõ
  • digital linear tape(DLT)
    µðÁöÅÐ Å×ÀÌÇÁ ÀúÀåÀåÄ¡
  • fine horizontal linear opacity
    ¹Ì¼¼ÇÑ ¼öÆò¸éÇü ¼±»ó ºÒÅõ¸íü
  • general linear model
    ÀϹÝÀû ¼±Çü¸ðµ¨, ÀÏ¹Ý ¼±»ó¸ðµ¨
  • linear
    ¼±»ó, ¼±Çü
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • linear array
    ¼±Çü ¹è¿­
  • linear correlation
    ¼±»ó»ó°ü
  • linear density
    ¼±»óÀ½¿µ
  • linear electronic scanner
    ¼±ÇüÀüÀڽĽºÄ³³Ê
  • linear fracture
    ¼±»ó°ñÀý
  • linear interpolation algorithm(LIA)
    ¼±»óº¸°£¿¬»ê
  • linear phased array
    ¼±ÇüÀ§»óÂ÷¹è¿­
  • linear scan
    ¼±Çü½ºÄµ
  • linear scan motion
    ¼±Çü½ºÄµ¿îµ¿
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LS lateral suspensor; left sacrum; left septum; left side; legally separated; leiomyosarcoma; length of...
DS dead air space; dead space; deep sedative; deep sleep; defined substrate; dehydroepiandrosterone sul...
LSc local scleroderma
PSS painful shoulder syndrome; physiologic saline solution; porcine stress syndrome; primary Sjogren syn...
SCD scleroderma; service-connected disability; sickle-cell disease; spinocerebellar degeneration; subacu...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LS Localized scleroderma
PSS Progressive Systemic Scleroderma
SRC Scleroderma renal crisis
SSc; scleroderma Systemic Sclerosis
SSc Systemic scleroderma
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • L94.1
    Linear scleroderma
    ¼±»ó ÇǺΰæÈ­Áõ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • circumscribed scleroderma
    ±¹ÇѼº °øÇÇÁõ
  • progressive scleroderma
    ÁøÇ༺ °øÇÇÁõ
  • scleroderma circumscripta
    ±¹ÇѼº °øÇÇÁõ
  • scleroderma in plaque
    ġų» °øÇÇÁõ
  • coefficient of linear thermal expansion
    ¿­ ÆØÃ¢ °è¼ö
    ¹°Ã¼ÀÇ ¿Âµµ¸¦ 1µµ »ó½Â½ÃÅ´¿¡ µû¸¥ ±æÀÌÀÇ Áõ°¡À².
  • fine horizontal linear opacity
    ¹Ì¼¼ÇÑ ¼öÆò¸éÇü ¼±»ó ºÒÅõ¸íü
  • linear
    ¼±»ó, ¼±Çü, ¼±»óÀÇ
    ¼±¿¡ ¼ÓÇϰųª ¼±°ú ´àÀº.
  • linear coefficient of expansion
    ¼± ÆØÃ¢ °è¼ö
    °íüÀÇ ¿­ ÆØÃ¢¿¡ µû¸¥ ±æÀÌÀÇ º¯È­ ºñÀ². 0 ¡É¿¡¼­ ±æÀÌ lÀÎ ¹°Ã¼°¡ ¿Âµµ º¯È­ d¿¡ ´ëÇØ dl¸¸Å­ ¿­ ÆØÃ¢ÇÒ ¶§,
  • linear coefficient of thermal expansion
    ¼± ¿­ ÆØÃ¢ °è¼ö
  • linear energy transfer
    ¼± ¿¡³ÊÁö ºÎ¿©
  • linear expansion
    ¼± ÆØÃ¢
    ¹°Ã¼ÀÇ ±æÀ̰¡ ´Ã¾î³ª´Â °Í. ƯÈ÷ ¹°Ã¼°¡ ÀÏÁ¤ ¾Ð·ÂÇÏ¿¡¼­ ¿ÂµµÀÇ º¯È­¿¡ µû¶ó Å©±â¸¦ º¯È­½ÃŰ´Â °ÍÀ» ¿­ ÆØÃ¢À̶ó°í ÇÑ´Ù.
  • linear IgA disease
    ¼±»ó ¸é¿ª ±Û·ÎºÒ¸° A Áúȯ
  • linear lichen planus
    ¼±»ó ÆíÆò ż±
  • linear nevus sebaceous syndrome
    ¼±»ó ¸ð¹Ý ÇÇÁö¼± ÁõÈıº
  • linear optical characteristics
    ¼±Çü ±¤ÇРƯ¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
progressive familial scleroderma A syndrome characterised by calcinosis cutis, Raynaud's phenomenon, sclerodactyly, and telangiectasia; usually due to scleroderma; autosomal dominant form of progressive systemic sclerosis.
(05 Mar 2000)
scleroderma <dermatology> Hardening of skin.
(04 Mar 1998)
scleroderma, circumscribed A chronic, localised hardening and thickening of the skin. Lesions may be categorised as morphea (guttate, profunda, pansclerotic) or linear (with or without melorheostosis or hemiatrophy). It is twice as common in women as in men. The condition is characterised by skin ischemia, lymphocytic infiltrates, swollen collagen bundles, and thickening of the dermis with reduction of subcutaneous fat.
(12 Dec 1998)
scleroderma, systemic A chronic, progressive dermatosis characterised by boardlike hardening and immobility of the affected skin, with visceral involvement, especially of lungs, oesophagus, kidneys and heart. It may be accompanied by calcinosis, raynaud's phenomenon, and telangiectasis (crest syndrome). It includes acrosclerosis and sclerodactyly.
(12 Dec 1998)
oesophagus: scleroderma <radiology> Females (80%), 35-55 years of age, decreased LES pressure, decreased peristalsis, smooth muscle atrophy with or without loose fibrosis, dermatomyositis may include involvement of upper 1/3 (striated), dysphagia to solids more than liquids (steakhouse syndrome), wide-open LES or HH, with or without basilar pulmonary fibrosis, other GI sites associated with CREST syndrome
(12 Dec 1998)
localised scleroderma A skin lesion that is characterised by the presence of localised, indurated, slightly depressed areas of thickened dermal tissue that may be white or yellow in colour and surrounded by a pink or purplish halo.
See: in cutaneus scleroderma.
(27 Sep 1997)
programming, linear A technique of operations research for solving certain kinds of problems involving many variables where a best value or set of best values is to be found. It is most likely to be feasible when the quantity to be optimised, sometimes called the objective function, can be stated as a mathematical expression in terms of the various activities within the system, and when this expression is simply proportional to the measure of the activities, i.e., is linear, and when all the restrictions are also linear. It is different from computer programming, although problems using linear programming techniques may be programmed on a computer.
(12 Dec 1998)
non-linear Not linear.
(05 Dec 1998)
superficial linear keratitis Spontaneous, painful keratitis with epithelial erosion and folds in Bowman's membrane.
(05 Mar 2000)
linear Pertaining to or resembling a line.
Origin: L. Linearis
(18 Nov 1997)
linear absorption coefficient That fraction of ionizing radiation absorbed in a unit thickness of a substance or tissue.
See: absorption coefficient.
(05 Mar 2000)
linear acceleration The rate of change of velocity without a change in direction; e.g., when the speed of an aircraft increases while flying a straight pathway.
(05 Mar 2000)
linear accelerator <apparatus> A sophisticated external beam radiotherapy machine which has the capabilities of focussing irradiation (although not very finely).
Acronym: LinAC
(16 Dec 1997)
linear amputation Amputation performed by a circular incision through the skin, the muscles being similarly divided higher up, and the bone higher still.
Synonym: guillotine amputation, linear amputation.
(05 Mar 2000)
linear atrophy Bands of thin wrinkled skin, initially red but becoming purple and white, which occur commonly on the abdomen, buttocks, and thighs at puberty and/or during and following pregnancy, and result from atrophy of the dermis and overextension of the skin; also associated with ascites and Cushing's syndrome.
Synonym: atrophoderma striatum, lineae albicantes, lineae atrophicae, linear atrophy, stretch marks, stria, striae atrophicae, striate atrophy of skin, traction atrophy, vergeture.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • linear
    ÁÙÀÇ
  • linear
    Á÷¼±ÀÇ(À¸·Î ÀÌ·ç¾îÁø);¼±ÀÇ
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • linear measure
    ôµµ
  • linear motor
    ¼±Çü¸ðÅÍ
  • linear programming
    ¼±Çü°èȹ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á